Welcome to kongre.net
Speaker
Head, Translational Medicine, Apellis Pharmaceuticals
Stephen Poor, Head, Translational Medicine at Apellis Pharmaceuticals, is speaking at 10th Complement-Based Drug Development Summit (Boston, United States of America, 8–10 Dec 2026) in the session “Deepening Understanding of Complement Biology in Ophthalmology to Enable Targeted Intervention & Improve Patient Outcomes”.
8–10 Dec 2026Boston, United States of America
Senior Vice President, Research, Graviton BioSciences
President & Chief Executive Officer, Cascade Biotechnology
Senior Director, Immunology, Seismic Therapeutics
Chief Executive Officer, Ikarovec
Principal Scientist, Sanofi
Senior Scientist, Sanofi
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Stephen Poor, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].